Trading Update

RNS Number : 9315O
Dechra Pharmaceuticals PLC
07 July 2010
 



 

Issued by Citigate Dewe Rogerson Ltd, Birmingham

Date: Wednesday, 7 July 2010

Dechra® Pharmaceuticals PLC

("Dechra" or "The Group")

Trading Update

 

The Board of Dechra issues the following update ahead of the publication of the Group's Preliminary Results for the year ended 30 June 2010 which will be announced on Tuesday 7 September 2010.

 

Group revenue for the year ended 30 June 2010 was approximately 5.3% ahead of the equivalent period last year.

 

European Pharmaceuticals

Revenue from this division increased by approximately 9.0% compared to last year with both specialist pet diets and pharmaceuticals showing solid growth.  Foreign currency fluctuations did not have a material impact on these numbers.

 

Our manufacturing business, Dales® Pharmaceuticals, performed well during the period due to improved efficiency and increased production of both our own and third party products.

 

US Pharmaceuticals

Overall revenue was approximately 36.6% higher than last year. Revenue from US Vetoryl® in the period was US$6.6 million.

 

Services

This division revenue grew by approximately 3.3% compared to last year.

 

Balance Sheet

Operating cash flow during the period was strong, resulting in a further reduction in net borrowings.

 

Summary

Although our markets have experienced slower rates of growth than historical levels, we have demonstrated solid progress compared to last year. The Group continues to perform robustly and in line with management expectations; we remain confident about our future growth prospects.

 

 

Enquiries:


Ian Page, Chief Executive

Fiona Tooley, Director

Simon Evans, Group Finance Director

Keith Gabriel, Senior Account Manager

Dechra Pharmaceuticals PLC

Citigate Dewe Rogerson

Telephone: + 44 (0) 1782 771100

Telephone: +44 (0) 121 362 4035

Mobile: +44 (0) 777 5642222 (IP)

Mobile: +44 (0) 778 570 3523 (FT)

Mobile: +44 (0) 777 5642220 (SE)


www.dechra.com

Ticker:  Full Listing (Pharmaceuticals): DPH

 

Trademarks appear throughout this release in italics.  Dechra and the Dechra 'D' logo are registered Trademarks of Dechra Pharmaceuticals PLC.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTRFMATMBIMBPM
UK 100

Latest directors dealings